Respiratory Infection and Pregnancy

The problem of treating influenza and acute respiratory infections in pregnant and breastfeeding women remains an urgent issue of global public health. Pregnant women belong to a high-risk group for respiratory infections due to hormonal and physiological changes occurring during gestation, which predispose them to a severe and complicated course of disease, especially in the third trimester of pregnancy. The limited number of medicinal products that are both effective and approved for use during pregnancy highlights the need to develop and implement new approaches to the prevention and treatment of acute respiratory viral infections (ARVI) in pregnant women. At present, one of the most promising directions is the use of drugs with antiviral properties that also enhance immune system function, thereby preventing complications and reducing reproductive losses.